[1]
“MENGUKUR KINERJA DAN RISIKO KEUANGAN EMITEN BUMN SUBSEKTOR INDUSTRI FARMASI (F211)”, Sebatik, vol. 28, no. 1, pp. 105–113, June 2024, doi: 10.46984/sebatik.v28i1.2444.